DiaSorin LIAISON HSV-2 Type Specific IgG, REF 310620
Published January 31, 2024 · Recall initiated: December 13, 2023
Summary
FDA records medical device Class II recall Z-0815-2024, published January 31, 2024 and initiated December 13, 2023. Recalling firm: Diasorin Inc.; Status: Ongoing; Reported quantity: 31992 units; Lot: UDI/DI 08056771600101, Lot Numbers: 136344, 136344A, 136344B, 136344C, 136520, 136520A, 136520B, 136520C, 136604, 136703, 136703A, 136703B, 136703C, 136775. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
DiaSorin has identified that lots 136344, 136344A, 136344B, 136344C, 136520, 136520A, 136520B, 136520C, 136604, 136703, 136703A, 136703B, 136703C 136775of LIAISON HSV-2 Type Specific IgG assay may produce increased equivocal and/or false positive results.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Diasorin Inc.
- Distributor
- Worldwide distribution - US Nationwide and the country of Canada.
- Lot
- UDI/DI 08056771600101, Lot Numbers: 136344, 136344A, 136344B, 136344C, 136520, 136520A, 136520B, 136520C, 136604, 136703, 136703A, 136703B, 136703C, 136775
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDADiaSorin LIAISON Q.S.E.T. Device Plus, REF 319060; intended for use in the preparation of human stoolDecember 18, 2024
- FDACefixime for Oral Suspension 100mg/5mL, 50 mL bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc.,February 7, 2024
- FDABudesonide Extended-Release Tablets 9mg, 30-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL,February 7, 2024
- FDATactiFlex Ablation Sensor Enabled Ablation Catheter, Models A-TFSE-FJ, 7.5 F shaft and an 8F distal section,January 31, 2024
- FDAbkActiv Ultrasound System 2300, Model numbers 2300-56 and 2300-66.January 31, 2024
- FDAParvovirus B19 IgG EIA kit Part No. V519IGUSSeptember 9, 2020
Questions about this recall
Was DiaSorin LIAISON HSV-2 Type Specific IgG, REF 310620 recalled?
Yes. FDA published recall Z-0815-2024 on January 31, 2024. Reported hazard: DiaSorin has identified that lots 136344, 136344A, 136344B, 136344C, 136520, 136520A, 136520B, 136520C, 136604, 136703, 136703A, 136703B, 136703C 136775of LIAISON HSV-2 Type Specific IgG assay may produce increased equivocal and/or false positive results.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail